Miglustat | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Miglustat
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Miglustat

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 3 USDMF, 1 JDMF, 1 EU WC, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

10 API Suppliers
3 USDMF
1 JDMF
1 EU WC
5 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 5 FDA Orange Book, 13 Europe, 2 Canada, 1 South Africa, 2 Listed Dossiers

23 FDF Dossiers
5 FDA Orange Book
13 Europe
2 Canada
1 South Africa
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

7 DKSH, 1 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 DFE Pharma, 1 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Lonza Capsugel, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 4 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

7 DKSH
1 Faran Shimi Pharmaceutical
3 Boai NKY Pharmaceuticals Ltd
3 Gangwal Healthcare
4 ACG Worldwide
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 DFE Pharma
1 Gangwal Chemicals
1 Ingredion Pharma Solutions
3 Lonza Capsugel
5 Microlex e.U
1 Pharmatrans-Sanaq
1 Pluviaendo
2 Prachin Chemical
1 Qualicaps
4 Roquette
1 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
1 Sigachi Industries
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Fillers, Diluents & Binders, 10 Lubricants & Glidants, 9 Disintegrants & Superdisintegrants, 8 Empty Capsules, 7 Thickeners and Stabilizers, 6 Coating Systems & Additives, 4 Co-Processed Excipients, 3 Direct Compression, 3 Coloring Agents, 2 Film Formers & Plasticizers, 1 Granulation, 1 Emulsifying Agents, 1 Taste Masking, 1 API Stability Enhancers, 1 Solubilizers, 1 Controlled & Modified Release

13 Fillers, Diluents & Binders
10 Lubricants & Glidants
9 Disintegrants & Superdisintegrants
8 Empty Capsules
7 Thickeners and Stabilizers
6 Coating Systems & Additives
4 Co-Processed Excipients
3 Direct Compression
3 Coloring Agents
2 Film Formers & Plasticizers
1 Granulation
1 Emulsifying Agents
1 Taste Masking
1 API Stability Enhancers
1 Solubilizers
1 Controlled & Modified Release

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 10 Finished Drug Prices, 1 Annual Reports

2 US Medicaid Prescriptions
10 Finished Drug Prices
1 Annual Reports

MARKET PLACE

7 APIs, 4 FDF Dossiers

7 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 1 US Exclusivities, 1 Health Canada Patents

7 US Patents
1 US Exclusivities
1 Health Canada Patents

$ API Ref.Price (USD/KG) : 27,132 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Janssen Inc.

filter Patent Reset all filters

1 All

01 12368814

filter Product Reset all filters

1 All

01 1Miglustat

filter Dosage Reset all filters

1 All

01 1Capsules

filter Exp Date Reset all filters

1 All

01 12020-04-20

Product Main Page

01

Janssen Inc.

Miglustat

Antibody Engineering

Not Confirmed

Janssen Inc.

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-04-20

Date Granted : 2010-09-07

Brand Name : ZAVESCA

Patent Number : 2368814

Filing Date : 2000-04-20

Strength per Unit : 100 mg

Dosage Form : Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-04-20

Date Granted : 2010-09-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?